ÂÜÀòÂÒÂ×

Dr Anke Arnold-Tugulu brought with her more than 15 years’ experience in the pharmaceutical industry when she joined Azafaros as Head of Regulatory Affairs in early 2022. An expert in the field, Dr Arnold-Tugulu has worked in various disease areas and at all stages of drug development, playing a key role in bringing vital new treatments onto the global market. From 2007 to 2014, she moved through the ranks within the Drug Regulatory Affairs Department at Actelion Pharmaceuticals Ltd. (Switzerland), holding a variety of positions with increasing responsibility. Following this, she became Regulatory Affairs Manager at Hoffmann La Roche in Basel. This position primarily focussed on the registration of new indications for RoActemra® in countries outside the USA.

Dr Arnold-Tugulu later joined CSL Behring as Director of Regulatory Affairs, leading in the therapeutic areas for transplantation and respiratory treatments in Europe. More recently, Dr Arnold-Tugulu has worked for smaller companies such as Agios, Zug CH (as Head of International Regulatory Affairs) and Swedish Orphan Biovitrum (Sobi), Basel CH (as Global Regulatory Lead for Aspaveli®/Empaveli™) in the field of rare diseases, primarily in oncology and haematology indications. She received her PhD in Biochemistry from the Swiss Federal Institute of Technology in Lausanne in 2007.